The Vall d´Hebron Institute of Oncology (VHIO) Seeks a “Senior Laboratory Technician” (Process Closed)
Reference: Ref. 08-2023
Application deadline: 30/06/2023
Number of vacancies: 1
Job description:
The Experimental hematology group is seeking a senior laboratory technician to support the Hematology Molecular Genetics Unit, which is focused on the diagnosis and follow-up of hematological diseases through molecular biomarkers.
Our team is seeking a highly motivated person to supervise the unit technically and to implement new technologies to advance the diagnosis of hematological diseases: hematologic neoplasms as well as hereditary disorders.
Duties:
- General: coordination of lab technicians, reagent ordering, equipment training, experimental troubleshooting.
- Experimentation as required, implementation of new molecular markers and techniques.
- Genetic analysis: Sanger sequencing, real-time PCR and Next Generation Sequencing among others.
- Database management.
Requirements:
- Studies: B.Sc. and M.Sc in the field of life sciences.
- Relevant laboratory experience in a biomedical laboratory focused on genetic analysis.
- Motivated and engaged with diagnosis of genetic diseases.
- Excellent organization and teamwork skills.
- Decision-making and problem-solving skills.
- Computer skills.
Additional information:
- English: understanding manufacturer guides, ability to review relevant literature.
- Experience in hematological disorders.
- Experience in Next Generation Sequencing analysis.
Application:
Applicants should send a full Curriculum Vitae and a cover letter to selecciorrhh@vhio.net including the reference “Ref. 08-2023” in email subject line. Please also attach the names and contacts of at least 2 references.
About VHIO:
Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO), has established itself as a comprehensive cancer center of proven excellence internationally. It is also thanks to VHIO’s optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d’Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d’Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO’s pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.
VHIO’s translation toward precision oncology: https://www.vhio.net
Vall d’Hebron Institute Oncology (VHIO) endorses the Requirements and Principles of the European Charter for Researchers, the Code of Conduct for the Recruitment of Researchers promoted by the European Commission and follows Equal Opportunities policies.
On 10th April 2018 VHIO was awarded the “HR Excellence in Research” logo. Our Institute was consequently granted permission to use the HR Excellence in Research Award logo as demonstration of its stimulating and favourable work environment in line with the Charter & Code.
